ERC PHARMA ALPHA
Board
1 director, last change in 2023Permanent representatives 1
Mandates through the years
2 names, the dashed line is todayERC Pharma
Director
Director
Eliane ZOMBEK
Director (not named in the articles)
Director (not named in the articles)
BoardEarliermandate already running before its first mention
Mandates as a list
- ERC Pharma
- Director, appointed by deed of 15-12-2023, still in office
- Eliane ZOMBEK
- Director (not named in the articles), appointed by deed of 09-09-2019, until 15-12-2023
- Manager, until 09-09-2019
Control
Capital
- Capital
- €18,592.01
- Source
- deed of 09-09-2019
Articles of association
deed of 09-09-2019 (in French)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
- “Frais de procédure et d'expertise pour moitié à charge du cédant et pour moitié à charge du ou des acquéreurs proportionnellement au nombre…”
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Third Thursday of June
Capital transactions
Capital over time
- 09-09-2019 Capital reduction of €87,750 · to €18,592.01 · repaid to the shareholders
- 09-09-2019 Converted to unavailable equity · €29,226.01